As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Taking care of your skin is more than just a beauty routine; it’s an investment in your future self. Whether you’re a ...

MacDonald worries about her adult son being complacent when it comes to administering his hemophilia medication.

US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...

Helsinn Group and ESTEVE sign a partnership agreement renewal to commercialize AKYNZEO® and ALOXI® in Germany Lugano, Switzerland - January 8, 2025 - Helsinn Group ("Helsinn"), a global pharmaceutical ...

The other way of looking at emergencies is anticipatory. This involves prevention; being ready for whatever may happen. Once ...

Helsinn Group and ESTEVE sign a partnership agreement renewal to commercialize AKYNZEO® and ALOXI® in Germany ...

Borderline Personality Disorder and Loneliness: Broadening the Scope of Treatment for Social Rehabilitation - ...

Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use ...

The public would rather have access to GPs and good treatment for serious diseases than a free health service, a new poll ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...

The new approach, which uses existing ultrasound technology, demonstrated an initial 94% sensitivity rate in tumour detection ...